| Torrent Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500420 |
NSE Symbol : TORNTPHARM |
P/E(TTM) : 64.67 |
|
ISIN Demat : INE685A01028 |
Div & Yield% : 0.14 |
EPS(TTM) : 65.99 |
|
Book Value(₹) : 249.83 |
Market Cap(₹Cr) : 144,440.05 |
Face Value(₹) : 5.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 9,682.44 | 8,532.90 | 7,695.20 | 6,742.32 | 6,450.57 |
| Other Income | 31.50 | 91.36 | 81.88 | 204.17 | 118.34 |
| Stock Adjustments | 9.04 | 68.61 | -128.44 | 18.34 | 150.14 |
| Total Income | 9,722.98 | 8,692.87 | 7,648.64 | 6,964.83 | 6,719.05 |
| EXPENDITURE : | |||||
| Raw Materials | 2,249.84 | 2,200.39 | 2,010.98 | 1,925.84 | 1,819.81 |
| Power and Fuel Cost | 134.25 | 143.43 | 153.21 | 140.00 | 122.04 |
| Other Manufacturing Expenses | 189.02 | 173.82 | 143.39 | 141.56 | 136.19 |
| Selling and Administration Expenses | 1,396.83 | 1,254.38 | 1,138.57 | 954.66 | 851.08 |
| Miscellaneous Expenses | 533.53 | 489.52 | 404.23 | 399.91 | 382.74 |
| Employee Benefit Expenses | 1,636.45 | 1,450.67 | 1,251.22 | 1,097.93 | 1,097.12 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 3,583.06 | 2,980.66 | 2,547.04 | 2,304.93 | 2,310.07 |
| Interest | 213.40 | 303.04 | 297.68 | 236.29 | 334.12 |
| Gross Profit | 3,369.66 | 2,677.62 | 2,249.36 | 2,068.64 | 1,975.95 |
| Depreciation | 759.48 | 761.05 | 672.34 | 602.43 | 609.84 |
| Profit Before Tax | 2,610.18 | 1,916.57 | 1,577.02 | 1,466.21 | 1,366.11 |
| Current Tax | 540.56 | 321.67 | 274.20 | 253.27 | 247.77 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 181.56 | 237.82 | 251.43 | 221.49 | -19.51 |
| Reported Net Profit | 1,888.06 | 1,357.08 | 1,051.39 | 991.45 | 1,137.85 |
| Extraordinary Items | -4.20 | 14.88 | 27.97 | 6.86 | 12.75 |
| Adjusted Net Profit | 1,892.26 | 1,342.20 | 1,023.42 | 984.59 | 1,125.10 |
| Adjustment below Net Profit | -27.14 | 0.44 | -7.07 | -1.55 | 7.21 |
| Profit/Loss Balance carried down | 3,736.39 | 3,394.21 | 3,212.92 | 2,899.91 | 2,093.30 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1,082.98 | 1,015.34 | 863.03 | 676.89 | 338.45 |
| P & L Balance carried down | 4,514.33 | 3,736.39 | 3,394.21 | 3,212.92 | 2,899.91 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 120.00 | 560.00 | 440.00 | 960.00 | 700.00 |
| Dividend Per Share(Rs) | 6.00 | 28.00 | 22.00 | 48.00 | 35.00 |
| Earnings Per Share-Unit Curr | 55.78 | 40.10 | 31.06 | 58.58 | 67.23 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 224.32 | 201.76 | 190.75 | 374.94 | 356.30 |
| Book Value(Adj)-Unit Curr | 224.32 | 201.76 | 190.75 | 187.47 | 178.15 |
